This American Academy of Ophthalmology initiative provides ophthalmologists with a focused update on the management of macular edema secondary to retinal vein occlusion (RVO), including the use of new intravitreal anti-VEGF therapies.
Featured Activities
Treatment of RVO with Macular Edema Using New Anti-VEGF Agents
Points of View
Credit Hours: 0.25 (15 min)
Addressing Treatment Burden for RVO with Macular Edema
Points of View
Credit Hours: 0.25 (15 min)